Lupin arm to acquire 43.38% stake in Multicare Pharmaceuticals Philippines for US $39.6 m

Lupin partners ERN to launch asthma and COPD treatment in Spain

Lupin Ltd has entered into a strategic collaboration with Spanish pharmaceutical company LABORATORIOS ERN S.A. for the launch of Luforbec (beclometasone/formoterol) in Spain, marking another step in the Indian drugmaker’s efforts to expand its respiratory portfolio across key international markets. The therapy, delivered through a pressurised metered dose inhaler (pMDI), is indicated for the treatment…

Read More
CEAT shares downgraded, target cut on cost pressures post Q4

RBI, SEBI plan derivatives on corporate bond indices to deepen debt market

SEBI Chairman Tuhin Kanta Pandey said the regulator is working with the Reserve Bank of India (Reserve Bank of India) to introduce derivatives linked to corporate bond indices, in a move aimed at deepening India’s debt market and improving liquidity in fixed-income instruments. Speaking at the ICICI Securities India Investor Conference 2026, Pandey said capital…

Read More
CCL Products guides for 15% volume growth in FY27 as coffee prices ease

CCL Products guides for 15% volume growth in FY27 as coffee prices ease

Hyderabad-based premium-quality coffee producer CCL Products remains optimistic about its growth prospects for FY27, with the company maintaining guidance of around 15% growth in both volumes and earnings despite volatility in global commodity markets. Praveen Jaipuriar, CEO of CCL Products India, “What we are guiding the market is that we will keep the volume growth…

Read More